Please enable JavaScript

Viewing offline content

Limited functionality available

Dismiss

Services
What's new
Industries
What's new
Insights
What's new
Careers
What's new
ZA-EN Location: South Africa-English

ZA-EN Location: South Africa-English

Life Sciences and Health Care

The Life Sciences and Health Care industry group strives to support clients in addressing the challenges that impact today’s industry. Deloitte member firms' global network engages with clients to develop innovative solutions to help them achieve their business missions.

The Africa Deloitte Health Equity Institute
Life Sciences and Health Care Home
Life Sciences
Health Care

All
Solutions
People

Deloitte Insights

Tech Trends 2022

Engineer your tech-forward future

08 Nov.

Event

FT Global Pharmaceutical & Biotechnology Conference

Mon. | 8 Nov. 2021 | 10:00 a.m. GMT

This industry-leading conference brings together the world’s biggest pharma companies and other major organizations across the life sciences and health care value chain. The annual event is essential to stay up to date with the innovation and growth across areas such as drug discovery, clinical trials and market access, and exploring new frontiers for business and growth.

Register to access recordings*

Opens in new window

Deloitte Insights

Overcoming challenges and achieving resilience: The changing role of health care finance leaders to help ensure long-term success

2021 Health care CFO study

Deloitte Insights

Future-proofing the business

Building a superior experience for health plan customers through digital transformation

Article

Deloitte Digital Dialogue powered by J&J

Enabling innovation in the NHI

Covid-19 has amplified the need for an improved healthcare system in order to better service our people.

Analysis

2021 global life sciences outlook

Possibility is now reality, sustaining forward momentum

Perspectives

Consumer technology for health systems

Insights from health system leaders

Deloitte Insights

Intelligent drug launch and commercial

Optimising value through AI

A report on how AI can improve biopharma launches and sales, helping to get the right drugs to the right patients and gain a competitive edge.

Deloitte Insights

Attract, engage, and build loyalty

How actionable segmentation can provide valuable insights about your health care customers

As health care companies cater to activated and empowered customers, understanding differences in their attitudes, behaviors, and needs is important. Intelligent segmentation can be essential for delivering a unique customer experience.

Deloitte Insights

Overcoming biopharma's trust deficit

Why people mistrust the biopharma industry--and what to do about it

Deloitte Insights

Personalized therapies in the Future of Health

Winning with digital medicine products

Deloitte Insights

Virtual health accelerated

How can health care organizations take advantage of the current momentum?

Analysis

2021 Global Health Care Outlook

Accelerating industry change

Rising health care costs. Changing patient demographics. Evolving consumer expectations. New market entrants. Complex health and technology ecosystems.

Deloitte Insights

Breaking barriers to digitalization in biopharma

The pandemic's impact on R&D and commercial operating models

Perspectives

The future of cybersecurity in health care

Managing emerging cybersecurity threats in health care

Explore the future of health through the lens of cyber risk and learn about six key drivers of cyber security that impact the health care industry.

Article

The future unmasked

Predicting the future of healthcare and life sciences in 2025

What does the future hold for the life sciences and healthcare industry? Our latest predictions report looks ahead to the year 2025 to help you see what’s coming and to keep your organisation moving forward.

Perspectives

Securing trust in the global COVID-19 supply chain

From development and delivery to acceptance and administration

COVID-19 vaccines and therapeutics, and the associated medical devices and consumables, present an urgent need for a protected supply chain and a system of traceability built around globally identified products.

Deloitte Insights

Biopharma leaders prioritize R&D, technological transformation, and global market presence

Findings from a new survey and analysis of investor calls in the first half of 2020

Deloitte Insights

Building resilience during the COVID-19 pandemic and beyond

How health care CFOs are navigating with an eye on the future

Article

Is the hospital of the future here today?

Transforming the hospital business model

Perspectives

COVID-19: Orchestrating the recovery of supply chains

Recover: “The new normal” starts now

Article

The future of biopharma

Reimagining traditional business models in 2040

Article

The impact of COVID-19 on medical schemes

Predictions

Six predictions for China's pharma & health care sector

What changes will COVID-19 drive in China’s health care system?

Analysis

The impact of COVID-19 on China's pharmaceuticals industry

Article

Findings from the Deloitte 2019 Health Care CEO Perspectives Study

Accelerating change is now a basic feature of the health care industry. Deloitte’s discussions with CEOs across the industry offer insights into drivers of change, priorities, and worries, and how the definition of success is evolving.

Perspectives

For CFOs, a prescription for facing the future of health

CFO Insights

Analysis

2020 Global life sciences outlook

Creating new value | Building blocks for the future

Article

Ten years on

Measuring the return from pharmaceutical innovation 2019

Perspectives

The future of health

How innovation will blur traditional health care boundaries

Article

Harnessing opportunities and managing risk in the future of health

Article

The health plan of tomorrow

Business model transformation is the only way to adapt to disruption

Article

The future of aging

What impact might the expansion of health span have on society?

Article

Forces of Change

The Future of health

Article

Under the spotlight

Data integrity in life sciences

Analysis

2019 Global Health Care Outlook

Shaping the future

Analysis

2019 Global life sciences outlook

Focus and transform| Accelerating change in life sciences

Article

Health care risk leaders are keeping their heads above water for now

But a tidal wave of new risks may force them to sink or swim

Article

High-value health care

Innovative approaches to global challenges

Article

The future of work

How can health systems and health plans prepare and transform their workforce?

Perspectives

Global Health Care Outlook 2017

Making progress against persistent challenges

Analysis

2017 Global life sciences outlook

Thriving in today’s uncertain market

Solutions

Life sciences supply chain

Helping to optimize, reinvent and improve supply chains for companies across the pharmaceutical, biotechnology and medical device industries. Read to learn more.

Similar topics

Life Sciences and Health Care

Ashleigh Theophanides

Africa Life Sciences & Health Care Industry Lead

atheophanides@deloitte.co.za

+27 11 209 8112

Contact Us
Submit RFP
Media enquiries

Global office directory Office locations

ZA-EN Location: South Africa-English

About Deloitte

Home
Newsroom
Code of Conduct
Report unethical conduct
Office locator
Global Office Directory
Press releases
Submit RFP
Contact us
Deloitte Insights Blog
Social Media
About Deloitte in Malawi
About Deloitte in Zimbabwe
About Deloitte in Mozambique
About Deloitte in Botswana
About Deloitte in Zambia
https://sacoronavirus.co.za

Services

Audit & Assurance
Consulting
Financial Advisory
Risk Advisory
Tax & Legal
Deloitte Private

Industries

Consumer
Energy & Resources
Financial Services
Life Sciences & Healthcare
Government and Public Services
Technology, Media & Telecom

Careers

Job search
Experienced Hires
Executives
Students
Life at Deloitte
Alumni

About Deloitte
Terms of use
Privacy
Cookies
PAIA Manual
About Deloitte Africa
Avature Privacy
Standard terms for the provision of goods and services to Deloitte & Touche

© 2022. See Terms of Use for more information.

Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee (“DTTL”), its network of member firms, and their related entities. DTTL and each of its member firms are legally separate and independent entities. Please see www.deloitte.com/about for a detailed description of DTTL and its member firms.